🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
72.67
-0.03 (-0.04%)
At close: Nov 20, 2026, 4:00 PM EST
72.70
+0.02 (0.03%)
After-hours: Nov 20, 2026, 7:30 PM EST

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of $11.42 billion. The enterprise value is $11.35 billion.

Market Cap11.42B
Enterprise Value 11.35B

Important Dates

The last earnings date was Friday, November 6, 2026, after market close.

Earnings Date Nov 6, 2026
Ex-Dividend Date Nov 13, 2026

Share Statistics

Bio-Techne has 157.09 million shares outstanding. The number of shares has decreased by -0.71% in one year.

Current Share Class 157.09M
Shares Outstanding 157.09M
Shares Change (YoY) -0.71%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 0.36%
Owned by Institutions (%) 101.58%
Float 156.38M

Valuation Ratios

The trailing PE ratio is 66.11 and the forward PE ratio is 34.84.

PE Ratio 66.11
Forward PE 34.84
PS Ratio 9.29
Forward PS 8.89
PB Ratio 5.27
P/TBV Ratio 12.59
P/FCF Ratio 37.04
P/OCF Ratio 33.81
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.88, with an EV/FCF ratio of 36.83.

EV / Earnings 66.01
EV / Sales 9.24
EV / EBITDA 34.88
EV / EBIT 42.60
EV / FCF 36.83

Financial Position

The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.13.

Current Ratio 2.28
Quick Ratio 1.53
Debt / Equity 0.13
Debt / EBITDA 0.82
Debt / FCF 0.93
Interest Coverage 30.05

Financial Efficiency

Return on equity (ROE) is 8.32% and return on invested capital (ROIC) is 9.52%.

Return on Equity (ROE) 8.32%
Return on Assets (ROA) 6.45%
Return on Invested Capital (ROIC) 9.52%
Return on Capital Employed (ROCE) 11.71%
Weighted Average Cost of Capital (WACC) 11.05%
Revenue Per Employee $409,399
Profits Per Employee $57,317
Employee Count3,000
Asset Turnover 0.48
Inventory Turnover 2.07

Taxes

In the past 12 months, Bio-Techne has paid $55.41 million in taxes.

Income Tax 55.41M
Effective Tax Rate 24.37%

Stock Price Statistics

The stock price has increased by +25.71% in the last 52 weeks. The beta is 1.28, so Bio-Techne's price volatility has been higher than the market average.

Beta (5Y) 1.28
52-Week Price Change +25.71%
50-Day Moving Average 72.58
200-Day Moving Average 63.56
Relative Strength Index (RSI) 50.14
Average Volume (20 Days) 3,169,399

Short Selling Information

The latest short interest is 7.70 million, so 4.90% of the outstanding shares have been sold short.

Short Interest 7.70M
Short Previous Month 7.55M
Short % of Shares Out 4.90%
Short % of Float 4.93%
Short Ratio (days to cover) 2.78

Income Statement

In the last 12 months, Bio-Techne had revenue of $1.23 billion and earned $171.95 million in profits. Earnings per share was $1.10.

Revenue1.23B
Gross Profit 812.71M
Operating Income 266.43M
Pretax Income 227.38M
Net Income 171.95M
EBITDA 325.38M
EBIT 266.43M
Earnings Per Share (EPS) $1.10
Full Income Statement

Balance Sheet

The company has $351.13 million in cash and $285.56 million in debt, with a net cash position of $65.57 million or $0.42 per share.

Cash & Cash Equivalents 351.13M
Total Debt 285.56M
Net Cash 65.57M
Net Cash Per Share $0.42
Equity (Book Value) 2.17B
Book Value Per Share 13.79
Working Capital 463.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $337.60 million and capital expenditures -$29.40 million, giving a free cash flow of $308.20 million.

Operating Cash Flow 337.60M
Capital Expenditures -29.40M
Depreciation & Amortization 58.95M
Net Borrowing -100.00M
Free Cash Flow 308.20M
FCF Per Share $1.96
Full Cash Flow Statement

Margins

Gross margin is 66.17%, with operating and profit margins of 21.69% and 14.00%.

Gross Margin 66.17%
Operating Margin 21.69%
Pretax Margin 18.51%
Profit Margin 14.00%
EBITDA Margin 26.49%
EBIT Margin 21.69%
FCF Margin 25.09%

Dividends & Yields

This stock pays an annual dividend of $0.32, which amounts to a dividend yield of 0.44%.

Dividend Per Share $0.32
Dividend Yield 0.44%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 29.11%
FCF Payout Ratio 16.31%
Buyback Yield 0.71%
Shareholder Yield 1.15%
Earnings Yield 1.51%
FCF Yield 2.70%
Dividend Details

Analyst Forecast

The average price target for Bio-Techne is $70.50, which is -2.99% lower than the current price. The consensus rating is "Hold".

Price Target $70.50
Price Target Difference -2.99%
Analyst Consensus Hold
Analyst Count 13
Revenue Growth Forecast (3Y) 8.28%
EPS Growth Forecast (3Y) 9.87%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Nov 30, 2022
Split Type Forward
Split Ratio 4:1

Scores

Bio-Techne has an Altman Z-Score of 13.91 and a Piotroski F-Score of 5.

Altman Z-Score 13.91
Piotroski F-Score 5